Portal de Periódicos da CAPES

Distribution of GABA A Receptor mRNA in the Motor Cortex of ALS Patients

2003; Oxford University Press; Volume: 62; Issue: 10 Linguagem: Inglês

10.1093/jnen/62.10.1041

1554-6578

Susanne Petri, K Krampfl, Fariba Hashemi, Claudia Grothe, Akira Hori, Reinhard Dengler, Johannes Bufler,

Cholinesterase and Neurodegenerative Diseases

The pathomechanism of amyotrophic lateral sclerosis (ALS) remains unclear. There is some evidence that excitotoxic cell death is involved in the degeneration of the motor nervous system, and that ligand-gated receptor channels play a role in the pathogenesis of the disease. Several electrophysiological and anatomical studies support the pathophysiological concept of an impaired inhibitory, namely GABAergic, control of the motoneurons in the cerebral cortex of ALS patients. The aim of our study was to investigate the expression of GABAA-receptor subunit mRNAs and the GABA synthesizing enzyme glutamic acid decarboxylase (GAD) in the motor cortex of ALS patients compared to tissue of control persons. We performed in situ hybridization histochemistry (ISH) on human postmortem motor cortex sections of ALS patients (n = 5) and age matched controls with no history of neurological disease (n = 5). The most intriguing finding was a significantly reduced mRNA expression of the α1-subunit in ALS patients while the level of β1-subunit mRNA was elevated in the patients group. This may indicate specific alterations of the GABAA receptor subunit composition and result in distinct physiological and pharmacological properties of these receptors in ALS patients.